Cargando…
Defining cell-matrix combination products in the era of pluripotency
Human pluripotent stem (hPS) cells provide an attractive opportunity for the manufacture of a wide array of therapeutic cell types. The challenges to commercialization include the thousand-fold diversity of cell types emerging from hPS cells and the associated difficulties in validating processes to...
Autores principales: | Sternberg, Hal, Janus, Jeffrey, West, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732326/ https://www.ncbi.nlm.nih.gov/pubmed/23567186 http://dx.doi.org/10.4161/biom.24496 |
Ejemplares similares
-
New methods to study the composition and structure of the extracellular matrix in natural and bioengineered tissues
por: Schiller, Jürgen, et al.
Publicado: (2012) -
Defining SARS-CoV-2 breakthrough infection needing hospitalization in mass vaccination era: from disease-centered to patient-centered care
por: Ticinesi, Andrea, et al.
Publicado: (2022) -
Matrix metalloproteinase-2, caveolins, focal adhesion kinase and c-Kit in cells of the mouse myocardium
por: Cho, Woo Jung, et al.
Publicado: (2007) -
The two-faced T cell epitope: Examining the host-microbe interface with JanusMatrix
por: Moise, Leonard, et al.
Publicado: (2013) -
Pluripotent Stem Cells for Retinal Tissue Engineering: Current Status and Future Prospects
por: Singh, Ratnesh, et al.
Publicado: (2018)